
Imeka is a brain imaging specialist company that leverages advanced white matter imaging combined with AI to analyze brain structure in greater detail. Their flagship product, ANDI, is a 510(k) cleared clinical software that provides high-quality Diffusion Tensor Imaging (DTI) reports for clinical use, enabling a deeper understanding of neuroinflammation, axonal integrity, and myelin integrity. Backed by years of R&D with leading pharmaceutical companies and MRI manufacturers, Imeka's technology is proven for its scientific rigor and technological advancement. The company focuses on key areas of brain pathology such as Traumatic Brain Injury (TBI), Alzheimer's disease (AD), and Multiple Sclerosis (MS), aiming to help clinicians improve patient care through detailed neuroimaging analysis.

Imeka is a brain imaging specialist company that leverages advanced white matter imaging combined with AI to analyze brain structure in greater detail. Their flagship product, ANDI, is a 510(k) cleared clinical software that provides high-quality Diffusion Tensor Imaging (DTI) reports for clinical use, enabling a deeper understanding of neuroinflammation, axonal integrity, and myelin integrity. Backed by years of R&D with leading pharmaceutical companies and MRI manufacturers, Imeka's technology is proven for its scientific rigor and technological advancement. The company focuses on key areas of brain pathology such as Traumatic Brain Injury (TBI), Alzheimer's disease (AD), and Multiple Sclerosis (MS), aiming to help clinicians improve patient care through detailed neuroimaging analysis.